AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
BENDAMUSTINE HYDROCHLORIDE
21 registrations across 3 African markets— 21 active
Markets with BENDAMUSTINE HYDROCHLORIDE
Recent registrations
| Brand / Product | Market | Holder | Status | Expires |
|---|---|---|---|---|
| XENDA 100 POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | HETERO LABS LTD | active | Oct 2030 |
| Bendamustine Hydrochloride for Injection 25mg Lyophilised powder for injection | 🇿🇲Zambia | Mylan Laboratories Limited | active | Dec 2029 |
| Bendamustine Hydrochloride for Injection100mg Lyophilised powder for injection | 🇿🇲Zambia | Mylan Laboratories Limited | active | Dec 2029 |
| RIBEND 100 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | May 2028 |
| RIBEND 25 | 🇿🇦South Africa | Innovata Pharmaceuticals | active | May 2028 |
| OOOMUBEN 25 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2028 |
| IBOZARD 25 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2028 |
| IBOZARD 100 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2028 |
| OMUBEN 100 mg | 🇿🇦South Africa | Aurogen South Africa (Pty) Ltd | active | Feb 2028 |
| BENDAMUSTINE 180 mg/4 ml DRL | 🇿🇦South Africa | Dr ReddyÆs Laboratories (Pty) Ltd | active | Feb 2028 |
| EQUIBEN 100 | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Feb 2028 |
| EQUIBEN 25 | 🇿🇦South Africa | Equity Pharmaceutical (Pty) Ltd | active | Feb 2028 |
| BENDOKEY 100 POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | EUGIA PHARMA SPECIALTIES LIMITED | active | Dec 2027 |
| BENDOKEY SOLUTION; INJECTION | 🇿🇼Zimbabwe | EUGIA PHARMA SPECIALTIES LIMITED | active | Dec 2027 |
| BENDAMUSTINE MYLAN POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED (OTL) | active | Dec 2027 |
| BENDAMUSTINE MYLAN POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | MYLAN LABORATORIES LIMITED (OTL) | active | Dec 2027 |
| BENDOKEY 25 POWDER/INJECTABLE; INJECTION | 🇿🇼Zimbabwe | EUGIA PHARMA SPECIALTIES LIMITED | active | Dec 2027 |
| BENDAMUSTINE 25mg MYLAN | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| BENDAMUSTINE 100 mg MYLAN | 🇿🇦South Africa | Viatris Healthcare (Pty) Ltd | active | Jan 1900 |
| BENDAMUSTINE 25 mg FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
| BENDAMUSTINE 100 mg FRESENIUS | 🇿🇦South Africa | Fresenius Kabi South Africa (Pty) Ltd | active | Jan 1900 |
BENDAMUSTINE HYDROCHLORIDE in Africa — Regulatory Overview
BENDAMUSTINE HYDROCHLORIDE is registered across 3 African markets with 21 total product registrations on file. Data is sourced directly from official national drug regulatory authorities including South Africa, Zimbabwe, Zambia. AfricaRegulatory refreshes this data daily from official government sources.
Of the 21 registrations, 21 (100%) are currently active. Regulatory affairs teams use AfricaRegulatory to track registration expiry dates, identify market incumbents, and monitor approval status across African markets without manual monitoring of each national regulator.